Medicinal product name Tysabri
Pharmaceutical form Solution for injection
Strength 150 mg 
Information from the MAH on shortages No information on expected shortages
Availability of medicinal product
Product No.Package sizeWholesalers' stock state
EU/1/06/346/002 KZSN2 Is available
Legal status Rx Prescription (Pr.)
KZS NHS Reimbursed medicines
Summary of product characteristics, package leaflet and labeling text  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
Risk minimisation measuresIzglītojošie materiāli ārstam Izglītojošie materiāli ārstam
Izglītojošie materiāli pacientam Izglītojošie materiāli pacientam
ATC code L04AG03 Immunosuppressants

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Is available (according to the information provided by wholesalers)
(42 containers)
Tamro N2
(150 mg/1 ml)
Glass pre-filled syringe 1722.69 
KZS*
EU/1/06/346/002  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
* Indication about medicine on the List of state reimbursed medicines is just informative. Source of the information is the National Health Service. For details please visit the NHS website.

Registration information

Marketing authorisation No. EU/1/06/346/002
Date of authorisation Jun 27, 2006
Marketing authorisation holder, country Biogen Netherlands B.V., Netherlands